Clinical Scorecard: Triglyceride-Glucose Index as a Predictor of Negative Cardiovascular Outcomes in Patients with Hypertension and Obstructive Coronary Artery Disease: Findings from a Cohort Study

At a Glance

Key Highlights

• 19.73% of patients experienced major adverse cardiovascular events (MACE) over 2 years.
• Each one-unit increase in the TyG index correlated with a 45.2% increased risk of MACE.
• The TyG index showed consistent predictive performance across different subgroups.
• Mendelian randomization indicated a causal relationship between elevated TyG index and adverse cardiovascular outcomes.

Guideline-Based Recommendations

Diagnosis

• Assess triglyceride-glucose index in patients with hypertension and obstructive coronary artery disease.

Management

• Implement risk stratification based on TyG index levels.

Monitoring & Follow-up

• Monitor TyG index as part of cardiovascular risk assessment in hypertensive patients.

Risks

• Elevated TyG index is associated with increased risk of all-cause death, non-fatal myocardial infarction, unplanned revascularization, and rehospitalization for unstable angina.

Patient & Prescribing Data

Patients aged 18-80 with essential hypertension and obstructive coronary artery disease.

Focus on managing triglyceride levels and monitoring TyG index for cardiovascular risk.

Clinical Best Practices

• Utilize the TyG index for early identification of patients at risk for adverse cardiovascular events.
• Incorporate TyG index monitoring into routine care for patients with hypertension and OCAD.

Related Resources & Content

• Study on TyG index and cardiovascular outcomes